Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily A Burger

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
European Journal of Public Health|November 30, 2017
Advancing the evaluation of cervical cancer screening: development and application of a longitudinal adherence metricKine Pedersen, Emily A Burger, Suzanne Campbell, et al.
British Journal of Cancer|August 4, 2017
Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in NorwayEmily A Burger, Kine Pedersen, Stephen Sy, et al.
Plos One|March 22, 2014
Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boysEmily A Burger, Stephen Sy, Mari Nygård, et al.
International Journal of Cancer|May 16, 2024
Sociodemographic characteristics associated with cervical cancer screening participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results from a randomized controlled trial among long-term non-attending women in NorwayBo T Hansen, Mari Nygård, Phil E Castle, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 28, 2023
Designing Guidelines for Those Who Do Not Follow Them: The Impact of Adherence Assumptions on Optimal Screening GuidelinesKine Pedersen, Ivar S Kristiansen, Stephen Sy, et al.
The Journal of Infectious Diseases|July 25, 2014
Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in NorwayEmily A Burger, Stephen Sy, Mari Nygård, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2018
Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelinesKine Pedersen, Emily A Burger, Mari Nygård, et al.
Gynecologic Oncology|August 21, 2016
Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testingKine Pedersen, Emily A Burger, Stephen Sy, et al.
International Journal of Cancer|November 6, 2021
Potential effectiveness of a therapeutic HPV intervention campaign in UgandaJennifer C Spencer, Nicole G Campos, Emily A Burger, et al.
BMC Public Health|April 17, 2014
Does the primary screening test influence women's anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian womenEmily A Burger, Mari Nygård, Dorte Gyrd-Hansen, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Public Health|November 30, 2017
Advancing the evaluation of cervical cancer screening: development and application of a longitudinal adherence metricKine Pedersen, Emily A Burger, Suzanne Campbell, et al.
British Journal of Cancer|August 4, 2017
Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in NorwayEmily A Burger, Kine Pedersen, Stephen Sy, et al.
Plos One|March 22, 2014
Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boysEmily A Burger, Stephen Sy, Mari Nygård, et al.
International Journal of Cancer|May 16, 2024
Sociodemographic characteristics associated with cervical cancer screening participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results from a randomized controlled trial among long-term non-attending women in NorwayBo T Hansen, Mari Nygård, Phil E Castle, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 28, 2023
Designing Guidelines for Those Who Do Not Follow Them: The Impact of Adherence Assumptions on Optimal Screening GuidelinesKine Pedersen, Ivar S Kristiansen, Stephen Sy, et al.
The Journal of Infectious Diseases|July 25, 2014
Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in NorwayEmily A Burger, Stephen Sy, Mari Nygård, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2018
Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelinesKine Pedersen, Emily A Burger, Mari Nygård, et al.
Gynecologic Oncology|August 21, 2016
Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testingKine Pedersen, Emily A Burger, Stephen Sy, et al.
International Journal of Cancer|November 6, 2021
Potential effectiveness of a therapeutic HPV intervention campaign in UgandaJennifer C Spencer, Nicole G Campos, Emily A Burger, et al.
BMC Public Health|April 17, 2014
Does the primary screening test influence women's anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian womenEmily A Burger, Mari Nygård, Dorte Gyrd-Hansen, et al.
Pageof 7